SEBASTIEN SIMON KAIROUZ
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology DECATUR, IL NPI 1396701009
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology IL Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$29,730.38
- Category: General Payments
- Program years: PY2018–2024
- Record count: 452
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,592.56 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,067.56 | 53 |
| Consulting Fee | $525.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $525.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $223.02 | 12 |
| E.R. Squibb & Sons, L.L.C. | $186.63 | 7 |
| ABBVIE INC. | $120.26 | 4 |
| Merck Sharp & Dohme Corporation | $87.11 | 5 |
| Celgene Corporation | $62.49 | 4 |
| Acerta Pharma LLC | $51.21 | 3 |
| Gilead Sciences, Inc. | $46.10 | 3 |
| PFIZER INC. | $45.71 | 2 |
| EISAI INC. | $44.74 | 2 |
| Exelixis Inc. | $22.62 | 1 |
| JAZZ PHARMACEUTICALS INC. | $22.42 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.96 | 1 |
| Astellas Pharma US Inc | $19.97 | 1 |
| EMD Serono, Inc. | $18.36 | 1 |
| GlaxoSmithKline, LLC. | $18.15 | 1 |
| Apellis Pharmaceuticals, Inc. | $17.76 | 1 |
| Incyte Corporation | $16.80 | 1 |
| Rigel Pharmaceuticals, Inc. | $15.83 | 1 |
| Tempus AI, Inc | $14.10 | 1 |
| Kyowa Kirin, Inc. | $13.32 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.